News
June 2023
Scientific and Clinical Outcomes and Impact of the United Kingdom Refractory Asthma Stratification Programme (RASP-UK)
November 2021
WS4 Mepolizumab Exacerbation (MEX) study primary manuscript published in Lancet Respiratory Medicine
May 2021
WS4 Mepolizumab Exacerbation (MEX) study primary manuscript published in Lancet Respiratory Medicine
January 2021
Summary of the WS4 MAPLE study published in Thorax
October 2020
VIDEO: Prof. Heaney gives an overview of the WS1 Biomarker stratification study and the emerging results
Pivotal WS1 Biomarker Stratification study primary manuscript published in the Lancet Respiratory Medicine
Summary of the WS1 Biomarker Stratification study primary manuscript by the American Pharmacists Association
September 2020
Summary of the WS1 Biomarker Stratification Study primary manuscript presented at ERS 2020
Summary of the WS4 MEX study presented at ERS 2020
Summary of the WS4 MAPLE study presented at ERS 2020
Primary manuscript for the GSK connected inhaler study published in the ERJ
September 2019
Summary of the GSK connected inhaler study badged to WS1 presented at ERS 2020
April 2019
Perspective article summarising the un-met needs in severe asthma and outlining current and potential future research in severe asthma
January 2019
Editorial from the Journal of Allergy and Clinical Immunology
December 2018
Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus
Manuscript published in European Respiratory Journal.
Sorting Out Nonadherence and Airway Inflammation in Treatment Escalation for Severe Asthma
Editorial from: American Journal of Respiratory and Critical Care Medicine.
October 2018
Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Non-Adherence in Severe Asthma
January 2018
Methodology paper for workstrand 1 of the RASP consortium
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.
June 2017
Methodology paper for workstrand 1 of the RASP consortium
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique improve clinical decision making? A protocol for a randomised controlled trial using electronic monitoring.
March 2017
Severe Asthma Report 2017 (Asthma UK)
A white paper describing RASP and how action is urgently needed to improve the prospects for people with severe asthma.
FYI News: Asthma UK discusses RASP
Asthma UK describes how action is urgently needed to improve the prospects for people with severe asthma.
November 2016
Twitter feed initiated
Keep informed of the latest findings to emerge from RASP
May 2016
RASP-UK on World Asthma Day
Noting the contribution of RASP in understanding severe asthma.
March 2016
Article on NIHR website about Work Strand 3 - 7 March 2016
Study offers hope for people with severe allergic asthma.
October 2015
Drug therapies in severe asthma – the era of stratified medicine
Examining the current status of novel treatments and research efforts to identify novel targets in the era of stratified medicines in severe asthma.
July 2015
Article in Thorax - 23 July 2015
Description of the RASP study and it's aims.
January 2015
Press Release - 29 January 2015
Press release to announce the awarding of an MRC grant to RASP UK.
Asthma UK press release describing the MRC support for the programme
Asthma UK: Announcing the award of the grant funding by the MRC.